期刊文献+

血清H-FABP在急性肺栓塞患者早期危险分层中的应用 被引量:3

Application of serum heart-type fatty acid binding protein level in the early risk stratification of actue pulmonary fmbolism
暂未订购
导出
摘要 目的评价心肌型脂肪酸结合蛋白(H-FABP)对急性肺栓塞(APE)患者早期危险分层的预测价值。方法 2011年9月~2012年11月收治的APE患者60例,其中高危组14例、中危组26例和低危组20例。均于确诊后未行抗凝或溶栓治疗前检测血清H-FABP(>6.5 ng/mL判定为阳性);同时检测心率、SaO2、PaO2、D-二聚体(DD),并于就诊后24 h内行超声心动图检查,测定肺动脉压力、右心室内径、肺动脉内径、左室舒张末内径、左室射血分数。结果低、中、高危组心率、DD、H-FABP呈显著递增趋势,SaO2、PaO2呈显著递减趋势(P<0.05或0.01);H-FABP阳性与阴性者的呼吸困难发生率及右心室功能指标差异均有统计学意义(P<0.05)。结论血清H-FABP检测对于APE诊断明确者可用于病情判定、预后评估,与超声心动图等联合检测可对APE进行更为准确的危险分层。 Objective To evaluate the value of heart fatty acid binding protein (H-FABP) in the early risk stratification of acute pulmonary embolism (APE) patients. Methods Totally 60 patients with APE were enrolled in this study, and were divided into three groups according to risk stratification : high risk group, moderate risk group and low risk group. The serum H-FABP level was detected after diagnosis and before treatment of antieoagulation or thrombolysis ( the positive standard is 〉 6.5 ng/mL) ; HR, SaO2, PaO2, D-Dimer (DD) were also detected, and the pulmonary artery pressure (PAP), right ventricular internal dimension (RVID), pulmonary artery internal dimension (PAID), left ventricular diastolic end diameter(LVDED) and left ventricular ejection fraction (LVEF) were detected by echocardiography 24 hs after diagnosis. Results HR, DD and H-FABP increased progressively, SaO2 and PaO2 decreased progressively (P 〈 0. 05 or 0. 01 ) ; The incidence of dyspnea and indicators for the right ventricular function also showed significant differences( P 〈 0. 05). Conclusions Serum H-FABP can be used for the condition judgement and prognosis evaluation in patients with APE, and can provide precise risk stratification combined with echocardiography.
出处 《山东医药》 CAS 2013年第7期32-34,共3页 Shandong Medical Journal
关键词 急性肺栓塞 心肌型脂肪酸结合蛋白 右心室功能 危险分层 acute pulmonary embolism fatty acid binding proteins right ventricular function risk stratification
  • 相关文献

参考文献7

  • 1Tapson VF. Advances in the diagnosis and treatment of acute pulmo- nary embolism[J]. F1000 Med Rep, 2012,4:9.
  • 2Kueher N, Rossi E, De Rosa M, et al. Massive pulmonary embol-ism [ J]. Circulation, 2006,113 (4) :577-582.
  • 3王洪兴,张显峰,佟倩.B型脑钠肽水平与急性肺栓塞严重性及预后的关系[J].中国老年学杂志,2012,32(4):812-813. 被引量:9
  • 4Torbicki A, Pettier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the european society of cardiology ( ESC ) [ J ]. Eur Heart J, 2008,29 (18) :2276-2315.
  • 5钱海燕,黄觊,杨跃进,杨艳敏,张朝阳,李志忠,张京梅.心脏型脂肪酸结合蛋白对急性肺栓塞早期危险分层和预后预测的价值[J].心肺血管病杂志,2012,31(4):433-436. 被引量:7
  • 6Kostrubiec M, Pruszczyk P, Kaczynska A, et al. Persistent NT- proBNP elevation in acute pulmonary embolism predicts early death [J]. Clin Chim Acts, 2007,382(1-2) :124-128.
  • 7Viswanathan K, Kilcullen N, Morrell C, et al. Heart type fatty acid-binding protein predicts long-term mortality and reinfarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative[ J ]. J Am Coll Cardiol, 2010,55 ( 23 ) : 2590- 2598.

二级参考文献13

  • 1Torbicki A,Perrier A,Konstantinides S,et al.Guidelines on thediagnosis and management of acute pulmonary embolism:theTask Force for the Diagnosis and Management of Acute Pulmona-ry Embolism of the European Society of Cardiology(ESC).EurHeart J,2008,29:2276-2315.
  • 2Boscheri A,Wunderlich C,Langer M,et al.Correlation of heart-type fatty acid-binding protein with mortality and echocardio-graphic data in patients with pulmonary embolism at intermediaterisk.Am Heart J,2010,160:294-300.
  • 3Dellas C,Puls M,Lankeit M,et al.Elevated heart-type fattyacid-binding protein levels on admission predict an adverse out-come in normotensive patients with acute pulmonary embolism.JAm Coll Cardiol,2010,55:2150-2157.
  • 4Puls M,Dellas C,Lankeit M,et al.Heart-type fatty acid-bindingprotein permits early risk stratification of pulmonary embolism.Eur Heart J,2007,28:224-229.
  • 5Vuilleumier N,Le Gal G,Verschuren F,et al.Cardiac biomark-ers for risk stratification in non-massive pulmonary embolism:amulticenter prospective study.J Thromb Haemost,2009,7:391-398.
  • 6Kasper W,Konstantinides S,Geibel A,et al.Management strat-egies and determinants of outcome in acute major pulmonary em-bolism:results of a multicenter registry.J Am Coll Cardiol,1997,30:1165-1171.
  • 7Müller-Bardorff M,Weidtmann B,Giannitsis E,et al.Releasekinetics of cardiac troponin T in survivors of confirmed severepulmonary embolism.Clin Chem,2002,48:673-675.
  • 8Dekker MS,Mosterd A,van't Hof AW,et al.Novel biochemicalmarkers in suspected acute coronary syndrome:systematic reviewand critical appraisal.Heart,2010,96:1001-1010.
  • 9Viswanathan K,Kilcullen N,Morrell C,et al.Heart-type fattyacid-binding protein predicts long-term mortality and re-infarctionin consecutive patients with suspected acute coronary syndromewho are troponin-negative.J Am Coll Cardiol,2010,55:2590-2598.
  • 10Kume N,Mitsuoka H,Hayashida K,et al.Soluble lectin-likeoxidized LDL receptor-1(sLOX-1)as a sensitive and specific bi-omarker for acute coronary syndrome—comparison with other bio-markers.J Cardiol,2010,56:159-165.

共引文献14

同被引文献40

  • 1McMahon CG, Lamont JV, Curtin E, et al. Diagnostic accuracy of heart-type fatty acld-bindlng protein for the early diagnosis of a- cute myocardial infarction[J]. Ame J Emerg Med, 2012,30(2): 267-274.
  • 2Kim KS,Lee HJ,Kim K,et al. Heart-type fatty acid binding pro- tein as an adjunct to cardiac troponin I for the diagnosis of myo- cardial infarction[J]. J Korean Med Sci,2011,26(1) :47-52.
  • 3Cubranic Z, Madzar Z, Matijevic S, et al. Diagnostic accuracy ol heart fatty acid binding protein (H-FABP) and glycogen phospho- rylase isoenzyme BB (GPBB) in diagnosis of acute myocardial in- farction in patients with acute coronary syndrome[J]. Biochem Med(zagreb) ,2012,22(2) :225-236.
  • 4de Lemos JA, Antman EM, Morrow DA, et al. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy[J]. Clin Chim Acta,2000,298(1-2) :85 97.
  • 5Niizeki T, Takeishi Y, Arimoto T, et al. Combination of heart- type fatty acid binding protein and brain natriuretie peptide can reliably risk stratify patients hospitalized for chronic heart failure [J]. Cire J,2011,69(8) :922-927.
  • 6Boscheri A,Wunderlich C, Langer M, et al. Correlation of heart- type fatty acid-binding protein with mortality and echocardio- graphic data in patients with pulmonary embolism at intermediate risk[J]. Am Heart J,2010,160(2) :294-300.
  • 7Chowdhury UK, Malik V, Yadav R, et al. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump com- parison by measuring high-sensitivity C-reactive protein, cardiac troponin l, heart-type fatty acid-binding protein, creatine kinase- MB,and myoglobin release[J]. J Thorac Cardiovaac Surg,2008, 135(10) : 1110-1119.
  • 8Malik V, Kale SC, Chowdhury UK, et al. Myocardial injury in coronary artery bypass grafting, on-pump versus off-pump corn-parison by measuring heart-type fatty-acid-binding protein release [J]. Tex Heart lnst J,2006,33(3) :321-327.
  • 9无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,38(8):675-690. 被引量:2031
  • 10袁晓利.应用血浆肌钙蛋白T评估急性肺栓塞的预后[J].中国医药导报,2011,8(5):136-136. 被引量:2

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部